Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts

Genes to Cells

Volumn 17, Issue 8, 2012, Pages 660-672

  Ozono, Eiko ^a,b   Komori, Hideyuki ^c   Iwanaga, Ritsuko ^d   Tanaka, Tatsuya ^b   Sakae, Takahiro ^b   Kitamura, Hodaka ^b   Yamaoka, Shoji ^a   Ohtani, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KWANSEI GAKUIN UNIVERSITY   (Japan)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TAP73 PROTEIN; TRANSCRIPTION FACTOR E2F; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; FIBROBLAST; GROWTH STIMULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CULTURE MEDIA; DNA-BINDING PROTEINS; E2F1 TRANSCRIPTION FACTOR; ETOPOSIDE; FIBROBLASTS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; MUTAGENESIS, SITE-DIRECTED; NUCLEAR PROTEINS; POINT MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SERUM; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84864323521     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2012.01617.x     Document Type: Article

References (32)

1. Das, S., El-Deiry, W.S. & Somasundaram, K. (2003) Regulation of the p53 homolog p73 by adenoviral oncogene E1A. J. Biol. Chem. 278, 18313-18320.
2. DeGregori, J. & Johnson, D.G. (2006) Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr. Mol. Med. 6, 739-748.
3. ARF tumor suppressor. Mol. Cell. Biol. 20, 273-285.
4. Dyson, N. (1998) The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262.
5. Ferguson, A.T., Evron, E., Umbricht, C.B., Pandita, T.K., Chan, T.A., Hermeking, H., Marks, J.R., Lambers, A.R., Futreal, P.A., Stampfer, M.R. & Sukumar, S. (2000) High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer. Proc. Natl Acad. Sci. USA 97, 6049-6054.
6. Flores, E.R., Sengupta, S., Miller, J.B., Newman, J.J., Bronson, R., Crowley, D., Yang, A., McKeon, F. & Jacks, T. (2005) Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7, 363-373.
7. Irwin, M., Marin, M.C., Phillips, A.C., Seelan, R.S., Smith, D.I., Liu, W., Flores, E.R., Tsai, K.Y., Jacks, T., Vousden, K.H. & Kaelin, W.G. Jr. (2000) Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407, 645-648.
8. Iwanaga, R., Komori, H., Ishida, S., Okamura, N., Nakayama, K., Nakayama, K.I. & Ohtani, K. (2006) Identification of novel E2F1 target genes regulated in cell cycle-dependent and independent manners. Oncogene 25, 1786-1798.
9. Iwanaga, R., Ohtani, K., Hayashi, T. & Nakamura, M. (2001) Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene 20, 2055-2067.
10. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.C., Valent, A., Minty, A., Chalon, P., Lelias, J.M., Dumont, X., Ferrara, P., McKeon, F. & Caput, D. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90, 809-819.
11. Kartasheva, N., Contente, A., Lenz-Stoppler, C., Roth, J. & Dobbelstein, M. (2002) p53 induces the expression of its antagonist p73DN, establishing an autoregulatory feedback loop. Oncogene 21, 4715-4727.
12. Kern, S.E., Kinzler, K.W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C. & Vogelstein, B. (1991) Identification of p53 as a sequence-specific DNA-binding protein. Science 252, 1708-1711.
13. Knudsen, E.S. & Wang, J.Y. (1997) Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol. Cell. Biol. 17, 5771-5783.
14. ARF gene expression. EMBO J. 24, 3724-3736.
15. Lau, L.M., Wolter, J.K., Lau, J.T., Cheng, L.S., Smith, K.M., Hansford, L.M., Zhang, L., Baruchel, S., Robinson, F. & Irwin, M.S. (2009) Cyclooxygenase inhibitors differentially modulate p73 isoform in neuroblastoma. Oncogene 28, 2024-2033.
16. Lissy, N.A., Davis, P.K., Irwin, M., Kaelin, W.G. & Dowdy, S.F. (2000) A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 407, 642-645.
17. Lowe, S.W., Cepero, E. & Evan, G. (2004) Intrinsic tumour suppression. Nature 432, 307-315.
18. Muller, H., Bracken, A.P., Vernell, R., Moroni, M.C., Christians, F., Grassilli, E., Prosperini, E., Vigo, E., Oliner, J.D. & Helin, K. (2001) E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15, 267-285.
19. Ohtani, K., Tsujimoto, A., Ikeda, M. & Nakamura, M. (1998) Regulation of cell growth-dependent expression of mammalian CDC6 gene by the cell cycle transcription factor E2F. Oncogene, 17, 1777-1785.
20. Kip1 promoter specifically sense deregulated E2F activity. Genes Cells 14, 89-99.
21. Pediconi, N., Ianari, A., Costanzo, A., Belloni, L., Gallo, R., Cimino, L., Porcellini, A., Screpanti, I., Balsano, C., Alesse, E., Gulino, A. & Levrero, M. (2003) Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat. Cell Biol. 5, 552-558.
22. Rogoff, H.A., Pickering, M.T., Frame, F.M., Debatis, M.E., Sanchez, Y., Jones, S. & Kowalik, T.F. (2004) Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2. Mol. Cell. Biol. 24, 2968-2977.
23. Savelyeva, I. & Dobbelstein, M. (2011) Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A. Oncogene 30, 86, 5-875.
24. Seelan, R.S., Irwin, M., van der Stoop, P., Qian, C., Kaelin, W.G. Jr. & Liu, W. (2002) The human p73 promoter: characterization and identification of functional E2F binding sites. Neoplasia 4, 195-203.
25. Sherr, C.J. (1996) Cancer cell cycles. Science 274, 1672-1677.
26. Sherr, C.J. & McCormick, F. (2002) The RB and p53 pathways in cancer. Cancer Cell 2, 103-112.
27. Stiewe, T. & Putzer, B.M. (2000) Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat. Genet. 26, 464-469.
28. Sun, Q., Ming, L., Thomas, S.M., Wang, Y., Chen, Z.G., Ferris, R.L., Grandis, J.R., Zhang, L. & Yu, J. (2009) PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells. Oncogene 28, 2348-2357.
29. Tomasini, R., Tsuchihara, K., Wilhelm, M., et al. (2008) TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev. 22, 2677-2691.
30. Urist, M., Tanaka, T., Poyurovsky, M.V. & Prives, C. (2004) p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev. 18, 3041-3054.
31. Yakovlev, A.G., Giovanni, S.D., Wang, G., Liu, W., Stoica, B. & Faden, A.I. (2004) BOK and NOXA are essential mediators of p53-dependent apoptosis. J. Biol. Chem. 279, 28367-28374.
32. Zhao, Y., Katzman, R.B., Delmolino, L.M., et al. (2007) The Notch regulator MAML1 interacts with p53 and functions as a coactivator. J. Biol. Chem. 282, 11969-11981.